KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Progyny (PGNY) EBIAT (2018 - 2025)

Progyny (PGNY) has disclosed EBIAT for 8 consecutive years, with $28.2 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT changed N/A to $28.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.3 million, a N/A change, with the full-year FY2025 number at $79.9 million, up 47.06% from a year prior.
  • EBIAT was $28.2 million for Q4 2025 at Progyny, up from $13.9 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $28.2 million in Q4 2025 to a low of $3.4 million in Q4 2022.
  • A 5-year average of $14.5 million and a median of $15.1 million in 2021 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: soared 1860.06% in 2021, then tumbled 77.4% in 2022.
  • Progyny's EBIAT stood at $15.1 million in 2021, then crashed by 77.4% to $3.4 million in 2022, then surged by 295.25% to $13.5 million in 2023, then dropped by 22.64% to $10.4 million in 2024, then surged by 170.99% to $28.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's EBIAT are $28.2 million (Q4 2025), $13.9 million (Q3 2025), and $17.1 million (Q2 2025).